CEBPB was described to have a pro-oncogenic role also in other HMs, such as anaplastic large cell lymphoma (ALCL)[46] as well as in different cancers, e.g., breast, colon, kidney, stomach, prostate, and ovaries [47,48]. The gene discussed is CEBPB; the disease is cancer.